1
|
Diederichs S, Bartsch L, Berkmann JC,
Fröse K, Heitmann J, Hoppe C, Iggena D, Jazmati D, Karschnia P,
Linsenmeier M, et al: The dark matter of the cancer genome:
Aberrations in regulatory elements, untranslated regions, splice
sites, non-coding RNA and synonymous mutations. EMBO Mol Med.
8:442–457. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18.
2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Li W, Notani D and Rosenfeld MG: Enhancers
as non-coding RNA transcription units: Recent insights and future
perspectives. Nat Rev Genet. 17:207–223. 2016.PubMed/NCBI View Article : Google Scholar
|
4
|
Sullenger BA and Nair S: From the RNA
world to the clinic. Science. 352:1417–1420. 2016.PubMed/NCBI View Article : Google Scholar
|
5
|
Sherstyuk VV, Medvedev SP and Zakian SM:
Noncoding RNAs in the regulation of pluripotency and reprogramming.
Stem Cell Rev Rep. 14:58–70. 2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Russo F, Fiscon G, Conte F, Rizzo M, Paci
P and Pellegrini M: Interplay between long noncoding RNAs and
MicroRNAs in cancer. Methods Mol Biol. 1819:75–92. 2018.PubMed/NCBI View Article : Google Scholar
|
7
|
Kim YK and Kook H: Diverse roles of
noncoding RNAs in vascular calcification. Arch Pharm Res.
42:244–251. 2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Li Q, Ahsan MA, Chen H, Xue J and Chen M:
Discovering putative peptides encoded from noncoding RNAs in
ribosome profiling data of Arabidopsis Thaliana. ACS Synth Biol.
7:655–663. 2018.PubMed/NCBI View Article : Google Scholar
|
9
|
Khurana E, Fu Y, Chakravarty D, Demichelis
F, Rubin MA and Gerstein M: Role of non-coding sequence variants in
cancer. Nat Rev Genet. 17:93–108. 2016.PubMed/NCBI View Article : Google Scholar
|
10
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016.PubMed/NCBI View Article : Google Scholar
|
11
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6(37)2013.PubMed/NCBI View Article : Google Scholar
|
12
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018.PubMed/NCBI View Article : Google Scholar
|
13
|
Uszczynska-Ratajczak B, Lagarde J,
Frankish A, Guigó R and Johnson R: Towards a complete map of the
human long non-coding RNA transcriptome. Nat Rev Genet. 19:535–548.
2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Atianand MK, Hu W, Satpathy AT, Shen Y,
Ricci EP, Alvarez-Dominguez JR, Bhatta A, Schattgen SA, McGowan JD,
Blin J, et al: A long noncoding RNA lincRNA-EPS acts as a
transcriptional brake to restrain inflammation. Cell.
165:1672–1685. 2016.PubMed/NCBI View Article : Google Scholar
|
15
|
Chen J, Yu Y, Li H, Hu Q, Chen X, He Y,
Xue C, Ren F, Ren Z, Li J, et al: Long non-coding RNA PVT1 promotes
tumor progression by regulating the miR-143/HK2 axis in gallbladder
cancer. Mol Cancer. 18(33)2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Cho H, Shen GQ, Wang X, Wang F, Archacki
S, Li Y, Yu G, Chakrabarti S, Chen Q and Wang QK: Long noncoding
RNA ANRIL regulates endothelial cell activities associated with
coronary artery disease by up-regulating CLIP1, EZR, and LYVE1
genes. J Biol Chem. 294:3881–3898. 2019.PubMed/NCBI View Article : Google Scholar
|
17
|
Lu H, Han N, Xu W, Zhu Y, Liu L, Liu S and
Yang W: Screening and bioinformatics analysis of mRNA, long
non-coding RNA and circular RNA expression profiles in
mucoepidermoid carcinoma of salivary gland. Biochem Biophys Res
Commun. 508:66–71. 2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Galamb O, Barták BK, Kalmár A, Nagy ZB,
Szigeti KA, Tulassay Z, Igaz P and Molnár B: Diagnostic and
prognostic potential of tissue and circulating long non-coding RNAs
in colorectal tumors. World J Gastroenterol. 25:5026–5048.
2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004.PubMed/NCBI View
Article : Google Scholar
|
20
|
Wu F, Sui Y, Wang Y, Xu T, Fan L and Zhu
H: Long noncoding RNA SNHG7, a molecular sponge for microRNA-485,
promotes the aggressive behavior of cervical cancer by regulating
PAK4. Onco Targets Ther. 13:685–699. 2020.PubMed/NCBI View Article : Google Scholar
|
21
|
Wu X, Yuan Y, Ma R, Xu B and Zhang R:
lncRNA SNHG7 affects malignant tumor behaviors through
downregulation of EZH2 in uveal melanoma cell lines. Oncol Lett.
19:1505–1515. 2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Xia Q, Li J, Yang Z, Zhang D, Tian J and
Gu B: Long non-coding RNA small nucleolar RNA host gene 7
expression level in prostate cancer tissues predicts the prognosis
of patients with prostate cancer. Medicine (Baltimore).
99(e18993)2020.PubMed/NCBI View Article : Google Scholar
|
23
|
She K, Huang J, Zhou H, Huang T, Chen G
and He J: lncRNA-SNHG7 promotes the proliferation, migration and
invasion and inhibits apoptosis of lung cancer cells by enhancing
the FAIM2 expression. Oncol Rep. 36:2673–2680. 2016.PubMed/NCBI View Article : Google Scholar
|
24
|
She K, Yan H, Huang J, Zhou H and He J:
miR-193b availability is antagonized by LncRNA-SNHG7 for
FAIM2-induced tumour progression in non-small cell lung cancer.
Cell Prolif. 51(e12406)2018.PubMed/NCBI View Article : Google Scholar
|
25
|
Chen K, Abuduwufuer A, Zhang H, Luo L,
Suotesiyali M and Zou Y: SNHG7 mediates cisplatin-resistance in
non-small cell lung cancer by activating PI3K/AKT pathway. Eur Rev
Med Pharmacol Sci. 23:6935–6943. 2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Lim JS, Jung GY and Park SY: Nkx-2.5
regulates MDR1 expression via its upstream promoter in breast
cancer cells. J Korean Med Sci. 34(e100)2019.PubMed/NCBI View Article : Google Scholar
|
27
|
Reustle A, Fisel P, Renner O, Büttner F,
Winter S, Rausch S, Kruck S, Nies AT, Hennenlotter J, Scharpf M, et
al: Characterization of the breast cancer resistance protein
(BCRP/ABCG2) in clear cell renal cell carcinoma. Int J Cancer.
143:3181–3193. 2018.PubMed/NCBI View Article : Google Scholar
|
28
|
Lu PW, Li L, Wang F and Gu YT: Inhibitory
role of large intergenic noncoding RNA-ROR on tamoxifen resistance
in the endocrine therapy of breast cancer by regulating the
PI3K/Akt/mTOR signaling pathway. J Cell Physiol. 234:1904–1912.
2019.PubMed/NCBI View Article : Google Scholar
|
29
|
Deng Y, Zhao F, Zhang Z, Sun F and Wang M:
Long noncoding RNA SNHG7 promotes the tumor growth and
epithelial-to-mesenchymal transition via regulation of miR-34a
signals in osteosarcoma. Cancer Biother Radiopharm. 33:365–372.
2018.PubMed/NCBI View Article : Google Scholar
|
30
|
Yi L, Zhou X, Li T, Liu P, Hai L, Tong L,
Ma H, Tao Z, Xie Y, Zhang C, et al: Notch1 signaling pathway
promotes invasion, self-renewal and growth of glioma initiating
cells via modulating chemokine system CXCL12/CXCR4. J Exp Clin
Cancer Res. 38(339)2019.PubMed/NCBI View Article : Google Scholar
|
31
|
Seid Alian N, Khodarahmi P and Naseh V:
The effect of cadmium on apoptotic genes mRNA expression of Bax and
Bcl-2 in small intestine of rats. Iran J Pathol. 13:408–414.
2018.PubMed/NCBI
|
32
|
Wu DM, Wang S, Wen X, Han XR, Wang YJ, Fan
SH, Zhang ZF, Shan Q, Lu J and Zheng YL: Long noncoding RNA nuclear
enriched abundant transcript 1 impacts cell proliferation,
invasion, and migration of glioma through regulating
miR-139-5p/CDK6. J Cell Physiol. 234:5972–5987. 2019.PubMed/NCBI View Article : Google Scholar
|
33
|
Zhang C, Hao Y, Wang Y, Xu J, Teng Y and
Yang X: TGF-β/SMAD4-regulated LncRNA-LINP1 inhibits
epithelial-mesenchymal transition in lung cancer. Int J Biol Sci.
14:1715–1723. 2018.PubMed/NCBI View Article : Google Scholar
|
34
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108.
2017.PubMed/NCBI View Article : Google Scholar
|
35
|
Gakis G, Witjes JA, Compérat E, Cowan NC,
De Santis M, Lebret T, Ribal MJ and Sherif AM: European Association
of Urology. EAU guidelines on primary urethral carcinoma. Eur Urol.
64:823–830. 2013.PubMed/NCBI View Article : Google Scholar
|
36
|
Li R, Metcalfe M, Kukreja J and Navai N:
Role of radical cystectomy in non-organ confined bladder cancer: A
systematic review. Bladder Cancer. 4:31–40. 2018.PubMed/NCBI View Article : Google Scholar
|
37
|
Zhong X, Long Z, Wu S, Xiao M and Hu W:
LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of
bladder cancer cells assurance guidelines. J BUON. 23:776–781.
2018.PubMed/NCBI
|
38
|
Chen Y, Peng Y, Xu Z, Ge B, Xiang X, Zhang
T, Gao L, Shi H, Wang C and Huang J: Knockdown of lncRNA SNHG7
inhibited cell proliferation and migration in bladder cancer
through activating Wnt/β-catenin pathway. Pathol Res Pract.
215:302–307. 2019.PubMed/NCBI View Article : Google Scholar
|
39
|
Xu C, Zhou J, Wang Y, Wang A, Su L, Liu S
and Kang X: Inhibition of malignant human bladder cancer phenotypes
through the down-regulation of the long non-coding RNA SNHG7. J
Cancer. 10:539–546. 2019.PubMed/NCBI View Article : Google Scholar
|
40
|
Attard G, Parker C, Eeles RA, Schröder F,
Tomlins SA, Tannock I, Drake CG and de Bono JS: Prostate cancer.
Lancet. 387:70–82. 2016.PubMed/NCBI View Article : Google Scholar
|
41
|
Qi H, Wen B, Wu Q, Cheng W, Lou J, Wei J,
Huang J, Yao X and Weng G: Long noncoding RNA SNHG7 accelerates
prostate cancer proliferation and cycle progression through cyclin
D1 by sponging miR-503. Biomed Pharmacother. 102:326–332.
2018.PubMed/NCBI View Article : Google Scholar
|
42
|
Han Y, Hu H and Zhou J: Knockdown of
LncRNA SNHG7 inhibited epithelial-mesenchymal transition in
prostate cancer though miR-324-3p/WNT2B axis in vitro. Pathol Res
Pract. 215(152537)2019.PubMed/NCBI View Article : Google Scholar
|
43
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019.PubMed/NCBI View Article : Google Scholar
|
44
|
Luo X, Song Y, Tang L, Sun DH and Ji DG:
LncRNA SNHG7 promotes development of breast cancer by regulating
microRNA-186. Eur Rev Med Pharmacol Sci. 22:7788–7797.
2018.PubMed/NCBI View Article : Google Scholar
|
45
|
Sun X, Huang T, Liu Z, Sun M and Luo S:
LncRNA SNHG7 contributes to tumorigenesis and progression in breast
cancer by interacting with miR-34a through EMT initiation and the
Notch-1 pathway. Eur J Pharmacol. 856(172407)2019.PubMed/NCBI View Article : Google Scholar
|
46
|
Gao YT and Zhou YC: Long non-coding RNA
(lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast
cancer progression by sponging miRNA-381. Eur Rev Med Pharmacol
Sci. 23:6588–6595. 2019.PubMed/NCBI View Article : Google Scholar
|
47
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–32. 2016.PubMed/NCBI View Article : Google Scholar
|
48
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018.PubMed/NCBI View Article : Google Scholar
|
49
|
Cui H, Zhang Y, Zhang Q, Chen W, Zhao H
and Liang J: A comprehensive genome-wide analysis of long noncoding
RNA expression profile in hepatocellular carcinoma. Cancer Med.
6:2932–2941. 2017.PubMed/NCBI View Article : Google Scholar
|
50
|
Neuzillet C, Tijeras-Raballand A, Bourget
P, Cros J, Couvelard A, Sauvanet A, Vullierme MP, Tournigand C and
Hammel P: State of the art and future directions of pancreatic
ductal adenocarcinoma therapy. Pharmacol Ther. 155:80–104.
2015.PubMed/NCBI View Article : Google Scholar
|
51
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
52
|
Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M
and Yang J: LncRNA SNHG7 promotes pancreatic cancer proliferation
through ID4 by sponging miR-342-3p. Cell Biosci.
9(28)2019.PubMed/NCBI View Article : Google Scholar
|
53
|
Xu LJ, Yu XJ, Wei B, Hui HX, Sun Y, Dai J
and Chen XF: LncRNA SNHG7 promotes the proliferation of esophageal
cancer cells and inhibits its apoptosis. Eur Rev Med Pharmacol Sci.
22:2653–2661. 2018.PubMed/NCBI View Article : Google Scholar
|
54
|
Chen D, Zhang Z, Mao C, Zhou Y, Yu L, Yin
Y, Wu S, Mou X and Zhu Y: ANRIL inhibits p15(INK4b) through the
TGFβ1 signaling pathway in human esophageal squamous cell
carcinoma. Cell Immunol. 289:91–96. 2014.PubMed/NCBI View Article : Google Scholar
|
55
|
Wu MZ, Wang S, Zheng M, Tian LX, Wu X, Guo
KJ, Zhang YI and Wu GP: The diagnostic utility of p16
immunostaining in differentiating cancer and HSIL from LSIL and
benign in cervical cells. Cell Transplant. 28:195–200.
2019.PubMed/NCBI View Article : Google Scholar
|
56
|
Wang MW, Liu J, Liu Q, Xu QH, Li TF, Jin S
and Xia TS: LncRNA SNHG7 promotes the proliferation and inhibits
apoptosis of gastric cancer cells by repressing the P15 and P16
expression. Eur Rev Med Pharmacol Sci. 21:4613–4622.
2017.PubMed/NCBI
|
57
|
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B
and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to
increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in
colorectal cancer progression. J Hematol Oncol.
11(89)2018.PubMed/NCBI View Article : Google Scholar
|
58
|
Shan Y, Ma J, Pan Y, Hu J, Liu B and Jia
L: LncRNA SNHG7 sponges miR-216b to promote proliferation and liver
metastasis of colorectal cancer through upregulating GALNT1. Cell
Death Dis. 9(722)2018.PubMed/NCBI View Article : Google Scholar
|
59
|
Lim M, Xia Y, Bettegowda C and Weller M:
Current state of immunotherapy for glioblastoma. Nat Rev Clin
Oncol. 15:422–442. 2018.PubMed/NCBI View Article : Google Scholar
|
60
|
Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ
and Sun Q: Long noncoding RNA SNHG7 promotes the progression and
growth of glioblastoma via inhibition of miR-5095. Biochem Biophys
Res Commun. 496:712–718. 2018.PubMed/NCBI View Article : Google Scholar
|
61
|
Zhang C, Zhu B, Li XB, Cao YQ, Yang JC, Li
X, Liu YX and Wang YB: Long non-coding RNA SNHG7 promotes migration
and invasion of melanoma via upregulating SOX4. Eur Rev Med
Pharmacol Sci. 23:4828–4834. 2019.PubMed/NCBI View Article : Google Scholar
|
62
|
Wang YH, Huo BL, Li C, Ma G and Cao W:
Knockdown of long noncoding RNA SNHG7 inhibits the proliferation
and promotes apoptosis of thyroid cancer cells by downregulating
BDNF. Eur Rev Med Pharmacol Sci. 23:4815–4821. 2019.PubMed/NCBI View Article : Google Scholar
|
63
|
Wu P, Tang Y, Fang X, Xie C, Zeng J, Wang
W and Zhao S: Metformin suppresses hypopharyngeal cancer growth by
epigenetically silencing long non-coding RNA SNHG7 in FaDu cells.
Front Pharmacol. 10(143)2019.PubMed/NCBI View Article : Google Scholar
|